- Home
- NIU vs ENLV Comparison
NIU vs ENLV Comparison
Compare NIU & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIU | ENLV |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.6M | 149.0M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NIU | ENLV |
|---|---|---|
| Price | $2.55 | $4.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 315.3K | 280.7K |
| Earning Date | 05-18-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.54 | N/A |
| Revenue Next Year | $17.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.93 | $0.43 |
| 52 Week High | $5.67 | $7.64 |
Technical Indicators
Market Signals| Indicator | NIU | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 57.84 |
| Support Level | $2.31 | $0.79 |
| Resistance Level | $3.24 | $7.64 |
| Average True Range (ATR) | 0.14 | 0.59 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 72.11 | 50.64 |
Price Performance
Historical ComparisonAbout NIU Niu Technologies
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.